Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 110001-110050 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT03260920
Intranasal Oxytocin for Frontotemporal Dementia
PHASE2
Active, not recruiting
112 participants
Started: Jan 31, 2018 · Completed: Dec 31, 2024
1 condition
4 sponsors
11 locations
NCT03919552
Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma
PHASE3
Recruiting
482 participants
Started: Jan 31, 2018 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT03537976
Targeting Surgeons' Decision-Making for Cleft Lip Surgery
NA
Active, not recruiting
48 participants
Started: Jan 31, 2018 · Completed: Aug 31, 2025
2 conditions
7 sponsors
2 locations
NCT03309332
AMPLATZER PFO Occluder Post Approval Study
NA
Active, not recruiting
1,214 participants
Started: Jan 31, 2018 · Completed: Feb 5, 2030
2 conditions
1 sponsor
89 locations
NCT03401385
First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)
PHASE1
Active, not recruiting
890 participants
Started: Jan 31, 2018 · Completed: Jan 1, 2027
3 conditions
3 sponsors
18 locations
NCT05758454
Caries-Obesity Prevention in Children by Modifying Risk Behaviors Among Parents With Immigrant Background-COP Study
NA
Recruiting
400 participants
Started: Jan 31, 2018 · Completed: Jun 30, 2026
1 condition
3 sponsors
2 locations
NCT03392246
A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer
PHASE2
Active, not recruiting
25 participants
Started: Jan 31, 2018 · Completed: Jun 30, 2026
1 condition
2 sponsors
4 locations
NCT03414021
Interest of the SPECT-CT Scan SUVspect in the New Generation of Gamma-cameras With Semiconductor
N/A
Recruiting
250 participants
Started: Jan 31, 2018 · Completed: Dec 30, 2025
5 conditions
1 sponsor
2 locations
NCT03417856
Defining the Skin and Blood Biomarkers of Ichthyosis
N/A
Enrolling by invitation
200 participants
Started: Jan 31, 2018 · Completed: Dec 31, 2025
2 conditions
3 sponsors
4 locations
NCT03328273
A Study of AZD6738 and Acalabrutinib in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
PHASE1
Active, not recruiting
12 participants
Started: Jan 31, 2018 · Completed: Aug 26, 2026
1 condition
1 sponsor
11 locations
NCT03424915
Exercise, Fitness and Tumor Profiling in Breast Cancer Patients
N/A
Active, not recruiting
42 participants
Started: Jan 31, 2018 · Completed: Jan 31, 2026
1 condition
1 sponsor
7 locations
NCT04414878
VitaFlow™ II Transcatheter Aortic Valve System Pre-market Trial
NA
Recruiting
145 participants
Started: Jan 31, 2018 · Completed: Jan 31, 2027
1 condition
1 sponsor
4 locations
NCT03275584
Safety of PET MPI Using the CRCHUM N-13 Ammonia
PHASE4
Recruiting
20,000 participants
Started: Jan 30, 2018 · Completed: Jan 31, 2028
1 condition
1 sponsor
1 location
NCT03344484
Midline Versus Paramedian Approaches in Treating Degenerative Lumbar Spondylolisthesis
NA
Recruiting
100 participants
Started: Jan 30, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03368963
TAS102 in Combination With NAL-IRI in Advanced GI Cancers
PHASE1/PHASE2
Active, not recruiting
64 participants
Started: Jan 30, 2018 · Completed: Nov 28, 2025
14 conditions
3 sponsors
3 locations
NCT06607471
Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study.
N/A
Recruiting
15,000 participants
Started: Jan 30, 2018 · Completed: Dec 31, 2035
15 conditions
1 sponsor
1 location
NCT02881242
Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate Cancer
PHASE2
Active, not recruiting
14 participants
Started: Jan 30, 2018 · Completed: Jan 31, 2025
4 conditions
4 sponsors
1 location
NCT03454035
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
PHASE1
Recruiting
45 participants
Started: Jan 30, 2018 · Completed: Nov 24, 2026
3 conditions
3 sponsors
1 location
NCT03498261
A Prospective Randomized Double Blind Trial to Assess the Effect of a Single Preoperative Dose of Gabapentin on Postoperative Opioid Consumption in Patients Undergoing Rhinoplasty
PHASE1
Active, not recruiting
50 participants
Started: Jan 30, 2018 · Completed: Dec 30, 2025
2 conditions
1 sponsor
1 location
NCT03414684
Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer
PHASE2
Active, not recruiting
78 participants
Started: Jan 30, 2018 · Completed: Jul 30, 2026
1 condition
2 sponsors
10 locations
NCT03475498
A Major Determinant Focused on the ECG or Echocardiogram for PICM and Its Clinical Outcome (PICM Syndrome)
N/A
Recruiting
1,000 participants
Started: Jan 30, 2018 · Completed: Feb 28, 2028
1 condition
5 sponsors
3 locations
NCT06103396
Treatment of Nonunion Fractures With Mesenchymal Stromal Cells (MSCs)
PHASE1/PHASE2
Enrolling by invitation
30 participants
Started: Jan 30, 2018 · Completed: Dec 30, 2024
4 conditions
3 sponsors
1 location
NCT04521790
Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management
N/A
Recruiting
1,000 participants
Started: Jan 30, 2018 · Completed: Dec 31, 2035
9 conditions
1 sponsor
1 location
NCT03422198
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
PHASE3
Recruiting
188 participants
Started: Jan 30, 2018 · Completed: Oct 31, 2029
9 conditions
1 sponsor
5 locations
NCT03376165
Post-Operative Myocardial Incident & Atrial Fibrillation
N/A
Recruiting
1,500 participants
Started: Jan 30, 2018 · Completed: Jan 31, 2028
2 conditions
1 sponsor
1 location
NCT03707808
Intratumoral Injection of Autologous CD1c (BDCA-1)+ MyDC, Avelumab, and Ipilimumab Plus Systemic Nivolumab
PHASE1/PHASE2
Recruiting
18 participants
Started: Jan 29, 2018 · Completed: Dec 24, 2025
2 conditions
1 sponsor
1 location
NCT03604835
Mucopolysaccharidosis VII Disease Monitoring Program
N/A
Recruiting
50 participants
Started: Jan 29, 2018 · Completed: May 31, 2033
4 conditions
1 sponsor
14 locations
NCT03333343
Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLC
PHASE1
Active, not recruiting
105 participants
Started: Jan 29, 2018 · Completed: Mar 9, 2026
1 condition
1 sponsor
11 locations
NCT03296592
Diffusion MRI in Cervical Spondylotic Myelopathy (CSM)
N/A
Active, not recruiting
71 participants
Started: Jan 29, 2018 · Completed: Dec 30, 2025
1 condition
2 sponsors
1 location
NCT03413423
Post Acute Cardiac Event Smoking (PACES) Study
NA
Active, not recruiting
233 participants
Started: Jan 29, 2018 · Completed: May 30, 2026
2 conditions
5 sponsors
1 location
NCT03330418
A Phase III Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Neuromyelitis Optica Spectrum Disorders
PHASE3
Recruiting
166 participants
Started: Jan 29, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03386539
Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score
PHASE3
Active, not recruiting
211 participants
Started: Jan 29, 2018 · Completed: Jan 31, 2024
7 conditions
3 sponsors
25 locations
NCT04246710
Pancreatic Cancer Molecular Sub-classification Using Endoscopic Ultrasound Tissue Core Biopsy Samples
N/A
Active, not recruiting
160 participants
Started: Jan 28, 2018 · Completed: Jun 2, 2024
1 condition
2 sponsors
1 location
NCT03186898
Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer
PHASE3
Recruiting
186 participants
Started: Jan 26, 2018 · Completed: Jun 30, 2027
3 conditions
2 sponsors
27 locations
NCT03481387
PERCEVAL S Valve Clinical Study for Chinese Registration
NA
Active, not recruiting
61 participants
Started: Jan 26, 2018 · Completed: Feb 25, 2024
2 conditions
1 sponsor
1 location
NCT02965755
Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins
NA
Active, not recruiting
200 participants
Started: Jan 26, 2018 · Completed: Jun 30, 2026
1 condition
4 sponsors
2 locations
NCT03131726
Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)
PHASE3
Recruiting
80 participants
Started: Jan 26, 2018 · Completed: Mar 30, 2028
3 conditions
2 sponsors
1 location
NCT04249973
Detection of Metabolite Biomarkers for the Early Diagnosis and Prognosis of Cow's Milk Allergy in Children
N/A
Active, not recruiting
81 participants
Started: Jan 26, 2018 · Completed: Mar 31, 2025
2 conditions
1 sponsor
8 locations
NCT03210103
Primary Radiotherapy Versus Primary Surgery for HPV-Associated Oropharyngeal Cancer
NA
Active, not recruiting
61 participants
Started: Jan 26, 2018 · Completed: Aug 15, 2028
1 condition
1 sponsor
9 locations
NCT03327779
World Bleeding Disorders Registry
N/A
Recruiting
20,000 participants
Started: Jan 26, 2018 · Completed: Jan 31, 2028
3 conditions
1 sponsor
1 location
NCT03676348
HRQOL in Thyroid Cancer and Thyroid Tumours
N/A
Recruiting
200 participants
Started: Jan 25, 2018 · Completed: Apr 30, 2028
3 conditions
1 sponsor
1 location
NCT03392987
A Safety and Efficacy Study of Cryopreserved OTL-200 for Treatment of Metachromatic Leukodystrophy (MLD)
PHASE2
Active, not recruiting
10 participants
Started: Jan 25, 2018 · Completed: Jan 31, 2026
2 conditions
2 sponsors
1 location
NCT03575832
Watchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveillance and Their Partners
NA
Active, not recruiting
64 participants
Started: Jan 25, 2018 · Completed: Dec 31, 2025
9 conditions
2 sponsors
2 locations
NCT03435042
A Hypnosis-based Group Intervention to Improve Quality of Life in Children With Cancer and Their Parents.
NA
Recruiting
30 participants
Started: Jan 25, 2018 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT06643221
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
EARLY_PHASE1
Recruiting
100 participants
Started: Jan 24, 2018 · Completed: Dec 30, 2028
6 conditions
2 sponsors
1 location
NCT05620329
UNC Pleural Fluid Registry
N/A
Recruiting
9,999 participants
Started: Jan 24, 2018 · Completed: Jan 24, 2050
5 conditions
1 sponsor
1 location
NCT03594981
Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis
PHASE1/PHASE2
Recruiting
36 participants
Started: Jan 24, 2018 · Completed: Nov 30, 2025
1 condition
2 sponsors
2 locations
NCT03417960
Accelerated iTBS for Post Partum Depression
NA
Recruiting
40 participants
Started: Jan 24, 2018 · Completed: Aug 30, 2027
1 condition
1 sponsor
1 location
NCT03417336
Study Evaluating the Efficacy and the Tolerance of Pelvic-prostatic Hypo-fractionated Radiotherapy Followed by Boost in Patients With Prostate Adenocarcinoma Adverse Intermediate Risk or High Localized Risk
NA
Recruiting
90 participants
Started: Jan 24, 2018 · Completed: Apr 24, 2029
1 condition
1 sponsor
2 locations
NCT03774732
PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer
PHASE3
Active, not recruiting
327 participants
Started: Jan 24, 2018 · Completed: Jul 22, 2027
3 conditions
2 sponsors
58 locations
Previous
1
More pages
2198
2199
2200
2201
2202
2203
2204
More pages
2369
Next